StockData

Yubo International Biotech Ltd (YBGJ) stock

YBGJOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.01+0.00 (0.00%)

Close on Oct 16, 2026Market cap $886.19KP/E –Yield –

Yubo International Biotech gross margin

Gross margin is gross profit as a percentage of revenue.

Yubo International Biotech's gross margin for the twelve months ending Jun 30, 2026 was 66.1%. For fiscal 2026 it was 66.1%, against 76.3% the year before. The highest annual figure on record is 76.3% in fiscal 2025.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2026Dec 31, 202566.1%−10.2
FY2025Dec 31, 202476.3%+7.0
FY2024Dec 31, 202369.3%+18.8
FY2023Dec 31, 202250.5%−15.5
FY2022Dec 31, 202165.9%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q4 FY2026CQ4 2025Dec 31, 202566.1%+4.2
Q1 FY2025CQ1 2024Mar 31, 202476.3%+39.5
Q4 FY2024CQ4 2023Dec 31, 202381.0%+37.5
Q3 FY2024CQ3 2023Sep 30, 202380.3%+14.5
Q2 FY2024CQ2 2023Jun 30, 202361.9%−11.5
Q1 FY2024CQ1 2023Mar 31, 202336.8%−17.5
Q4 FY2023CQ4 2022Dec 31, 202243.5%−22.4
Q3 FY2023CQ3 2022Sep 30, 202265.8%−8.6
Q2 FY2023CQ2 2022Jun 30, 202273.4%–
Q1 FY2023CQ1 2022Mar 31, 202254.3%–
Q4 FY2022CQ4 2021Dec 31, 202165.9%–
Q3 FY2022CQ3 2021Sep 30, 202174.5%–

More Yubo International Biotech figures

See a number that looks wrong?